Analyst Ratings for AstraZeneca (AZN)

AZN Rating Summary

AZN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AZN
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $64.17 (+16.2%) * Over Last 12-Mos
Rating Score: 6.1 / 10   Percentile Rank: 64%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/12/2021 Argus
» Updated 4/14/2021
John Eade Downgrade Hold
(Buy)
N/A
(N/A)
49.94
(55.21)
10.55% Details
3/16/2021 Jefferies Ian Hilliker Upgrade Buy
(Hold)
61.50
(56.00)
48.77
(55.21)
13.2% Details
Like AZN Ratings? Also take a look at PFE, MRNA, JNJ, BNTX

AZN Ratings News